Minutes of meetings of the

Cochrane Collaboration Steering Group

Melbourne, Australia

21 and 24 October 2005

 

[These minutes were approved by the Steering Group Executive on 28 November 2005.]

 

 

Topic

Item no.

Advisory Group, Cochrane CENTRAL

21.3; 22.4

[Advisory] Group, Cochrane Library Users’

21.4

Advisory Group, Colloquium Policy

21.5

Advisory Group, Feedback Management

21.6

Advisory Group, Handbook

21.7

[Advisory] Group, Information Management System

8.2; 21.8

Advisory Group, Quality

21.9

Amsterdam mid-year meetings of Centre Directors and Steering Group

25.3

Annual General Meetings, conduct and format

10

Campbell Collaboration, liaison

21.16

CENTRAL

21.3; 22.4

Centre Directors’ mid-year meetings in 2006, 2007 and 2008

22.4; 25; 26

Centre representation on the Steering Group

15.3

Centres, report from entity representatives

22.4

Chairs of the Steering Group, report from Co-

3.4; 4

Chairs, overlap of; nominations for new Co-

3.3.2

Chief Executive Officer contract renewal

5

Chief Executive Officer, report from the

7

Cochrane Foundation operating rules

6.5

Cochrane Library, continuation of the CD-ROM

22.4

Cochrane Library, national provisions of

11.2

Cochrane Library, quality, accessibility, derivative products

11.1

Cochrane Review Groups, report from entity representatives

22.1

Cochrane Review Groups, support for RGCs and TSCs

8.3

Cochrane Review, cost of a

12

Cochrane Reviews of diagnostic test accuracy

20

Cochrane Reviews, commissioned

3.4

Cochrane Reviews, methods for updating

21.13

Cochrane Reviews, plagiarism in

3.3.1

Cochrane Reviews, plain language summaries of

22.5.1

Cochrane Reviews, prioritisation of key topics for

14

Colloquium Manager software

27

Colloquia (Dublin, 2006; São Paulo, 2007; Germany, 2008)

28

Consumer Network, report from entity representatives

22.5

Consumers, access to The Cochrane Library for contributing Cochrane

22.5.2

Contact information working group, proposal for a

3.13.13

Co-ordinating Editors

17; 22.1.3

Cost of a Cochrane review

12

CRG editorial teams, guiding principles for

15.1.1

Declarations of interest by Steering Group members and staff

2; Appendix

Developing countries initiative

13

Discretionary Fund expenditure

6.4

Dublin Colloquium in 2006

25.2; 28

Elections, nominations for Co-Chair of the Steering Group

3.3.2

Elections, Steering Group

15;22.1.2;22.1.3

Entity representatives, verbal reports from

22

Fields/Networks, report from entity representatives

22.3

Finance, cash flow forecast

6.2

Finance, current financial position

6.2

Financial reporting of charity accounts

6.3

Financial Statements, Report and

6.1

Funders’ Forum, disbandment of

4; 21.15

Funding Arbiter

21.14

Germany, Colloquium in 2008

28

Impact factors

11.2

IMS Support Team

8.3

Information Management System developments

8.1

Information Management System Group report

8.2; 21.8

Information Management System, copyright of

3.9.6

James Lind Alliance

19

Job description, Publication Arbiter

21.11

Kenneth Warren Prize 2005

10.2

Khon Kaen mid-year meetings of Centre Directors and Steering Group

25.1

Methodological quality improvement projects

22.2.1

Methods Group, Adverse Events

22.2.4

Methods Group, Qualitative

22.2.3

Methods Groups, funding for

22.2.2

Methods Groups, report from entity representative

22.2

Mid-year meetings of Centre Directors and Steering Group

22.4; 25; 26

Monitoring and Registration Group, report from the

21.2

Monitoring/review of the Steering Group

16; 22.4

National provisions of The Cochrane Library

11.2

Ombudsman

21.10

Plagiarism in Cochrane Reviews

3.3.1

Plain language summaries of Cochrane Reviews

22.5.1

Priority setting for the next four years

3.8.1

Publication Arbiter issues

3.13.10

Publication Arbiter job description

21.11

Publishing Policy Group membership

21.1

Review Group Co-ordinators

22.1.1

Review/monitoring of the Steering Group

16; 22.4

São Paulo Colloquium in 2007

28

Science Citation Index

11.2

Skype software

15.1

Steering Group elections

15

Steering Group membership of sub- and advisory groups

17

Steering Group mid-year meetings in 2006, 2007 and 2008

22.4; 25; 26

Steering Group, comments from outgoing members

18

Steering Group, monitoring/review of the

16; 22.4

Steering Group, nominations for Co-Chair of the

3.3.2

Strategic global health leadership opportunities

14; 19; 22.4

Trading Company Directors, issues raised by the

24

Treasurer’s report on financial and legal matters

6

Trials’ Search Co-ordinators’ concerns re Steering Group representation 

15.2; 22.1.2

Tsunami Working Party, report from the

21.12

Umbrella reviews, report from working group on

23

Updating reviews, report from working group on

21.13

Vellore, India, mid-year meetings of Centre Directors and Steering Group

26

Website development project

9

Wiley, John and Sons Ltd

4;11;21.7;21.13;22.4


 Minutes of meetings of the

Cochrane Collaboration Steering Group

Melbourne, Australia

21 and 24 October 2005

[These minutes were approved by the Steering Group Executive on 28 November 2005.]

 

Present (Steering Group members shown in bold typeface): Godwin Aja (for items 10 to 30), Claire Allen, Lorne Becker, Lisa Bero, Mark Davies (Chair for items 10 to 18), Jon Deeks, Deborah Dixon (John Wiley & Sons, for item 11 only), Zbys Fedorowicz, Davina Ghersi (for items 1 to 18 only), Donna Gillies, Adrian Grant, Sally Green (not present for discussion of items 21.14 to 21.16, or 22 to 24), Jini Hetherington (minutes), Monica Kjeldstrøm (Director, Information Management System, and representative of the Trading Company Directors, not present for discussion of items 19-20; 21.11; 21.13; 21.14-16: 22.1-22.3; 22.5; 25-30), Steff Lewis (Chair for items 19 to 30), Alessandro Liberati (for items 15 and 16 only), Pisake Lumbiganon (for item 24.1 only), Dorothy de Moya (The Campbell Collaboration), Jim Neilson (Chair for items 1 to 9, and then present only for items 10 to 18), Jordi Pardo, Deborah Pentesco-Gilbert (John Wiley & Sons, for item 11 only), Nick Royle, Rob Scholten, Peter Tugwell, Herbert Turner (The Campbell Collaboration), Janet Wale, Liz Waters, Narelle Willis, Hans van der Wouden and Diana Wyatt (except for items 11 to 18).

 

 

1.            Welcomes, apologies for absence, introductions, and approval of the agenda

            Jim welcomed everyone to the meeting, especially the four incoming members (Donna Gillies, Adrian Grant, Narelle Willis and Hans van der Wouden), and Diana Wyatt (Secretary/Administrative Assistant in the Cochrane Collaboration Secretariat). He also welcomed Dorothy de Moya and Herbert Turner who were attending the meeting on behalf of The Campbell Collaboration. Godwin Aja had sent his apologies for being unable to attend the meeting for items 1 to 9. Everyone introduced themselves. Jim explained for the benefit of incoming Steering Group members that the mid-year meeting is the better opportunity to discuss items in depth than the shorter meeting during the Colloquium. New members officially join the Steering Group at the Annual General Meetings (AGMs), but Jim encouraged them to participate actively in the Steering Group meeting before the AGM as well. He explained that he, Mark and Steff would take it in turns to chair the two Steering Group meetings. The order of several agenda items was rearranged, although the order of the minutes follows the order shown on the agenda. Items 21.3, 21.8 and 22.4 were dealt with at the first Steering Group meeting on 21 October; items 15 and 16 were dealt with at the second Steering Group meeting on 24 October.

2.            Steering Group members’ declarations of interest

            No-one had anything to add to their existing declarations of interest, which are appended to these minutes. Lisa had provided the template for these statements and there had been some confusion about sources of funding from non-commercial organisations. Lisa explained that ‘related organisation’ was defined more broadly than ‘commercial source’ in the commercial sponsorship policy of The Cochrane Collaboration. This is because the Steering Group is involved in a wide variety of activities of The Cochrane Collaboration. For example, personal financial ties to publishing companies would not be a potential conflict related to review production by a Cochrane author, but would be considered a potential conflict for a Steering Group member, as the Steering Group is involved in business decisions related to publication. 
Action: Jini


3.         Matters arising from minutes of the previous meeting, not on this agenda:

 

3.3.1         Plagiarism in Cochrane reviews:  Jim reported that Mike Clarke had undertaken to write a discussion document on this subject, but it had since been decided that this was not a high priority item and would take a great deal of work which Mike had been unable to find the time for. This item needs no further discussion.

3.3.2     Overlap of Co-Chairs to provide continuity; nominations for replacement Co-Chair from October 2006: Jim explained for the benefit of new members that the two Co-Chairs step down from the Steering Group in different years, in order to provide continuity. He drew attention to the fact that Steering Group members should be starting to think soon about who they consider a suitable candidate to succeed Mark as Co-Chair in October 2006. Nominations will be considered at the next Steering Group meeting in Khon Kaen, Thailand, from 24 to 26 April 2006.
Post hoc note: See section 1.5.4.7 of The Cochrane Manual for the job description of Co-Chair, and the procedure to be followed in electing someone to this position.
Action: Everyone

3.4        Report from the Chair: Jim referred to his report to the previous Steering Group meeting in Providence, as the result of which, Peter, Davina and Lorne had undertaken to canvass their constituents’ views on whether entities would wish to take on commissioned systematic reviews should the opportunity arise. Davina reported that nothing had yet been done about this. Adrian and Narelle therefore undertook to canvass Co-ordinating Editors’ and RGCs’ views respectively, and convey these views to the Steering Group by the end of this year.
Action: Adrian, Narelle

3.8.1     Progress and priority setting for the next four years: Jim asked Nick to circulate a copy of the Collaboration’s Strategic Plan to the new Steering Group members, after he had attached new names, where appropriate, to action points.
Action: Nick

3.9.6     Copyright of IMS software: Nick advised that the licensing agreement between Rigshospitalet (the host institution of the Nordic Cochrane Centre) and The Cochrane Collaboration for the Information Management System software had been signed, recognising that copyright to the IMS belonged to Rigshospitalet but that the Collaboration had complete freedom to use the software. Nick clarified that the Collaboration would receive a proportion of any revenue if Rigshospitalet were to license the use of the IMS and related software to any third party. Nick paid tribute to the spirit of continued co-operation and support with which Rigshospitalet had conducted these discussions.

3.13.10   Publication Arbiter issues: Davina reported that progress had been made with the Cochrane review that had been discussed at the previous Steering Group meeting in Providence in April 2005.

3.13.13   Contact Information Working Group: Nick had obtained legal advice on the matter of access to the contact details of members of the Collaboration and passed it on. Jini explained that the working group that has proposed the establishment of the  new advisory group would report to the Steering Group at its next meeting in Khon Kaen in April 2006.
Action: Jini, Claire, Monica

15.1.1   Guiding principles for CRG editorial teams: Davina reported that she would raise the suggestion of compiling a set of guiding principles for CRG editorial teams, similar to those produced for Centre staff, at the various entity meetings during this Colloquium, and report back to the Steering Group via e-mail shortly after the Colloquium.
Action: Davina

4.         Report from the Co-Chairs

Mark highlighted the important progress that had been made now that ISI had agreed to include The Cochrane Database of Systematic Reviews (CDSR) in the Science Citation Index. He said that data had begun to be collected from the beginning of 2005. The CD-ROM version of The Cochrane Library is now being wholly produced by Wiley, and users are being surveyed towards the end of this year. Mark described a working group that had been set up to focus on improving the interface of The Cochrane Library; several usability sessions run by Wiley had produced some very interesting results. There had been significant progress with the establishment of an Evidence-Based Child Health Journal as a derivative product. Several copyright issues had recently been resolved thanks to Nick, and there had been some developments with regard to the possibility of national provision of The Cochrane Library in Europe. The issue of CENTRAL would be discussed in depth later in this meeting. The Funding Working Party was to hold a meeting within the next few days. Jim added that for the past five years there had been a meeting at each Colloquium of actual and potential funders, known as the Funders’ Forum. He reported that by mutual agreement this Forum had now been disbanded, and Nick would be asking Ron Stamp of the UK Department of Health to shut down the Funders’ Forum website as soon as possible, or put a message onto the site explaining that the Forum had been disbanded. There was some discussion about relationships with the Collaboration’s funders and the need to think strategically in the longer term. Sally was asked to stress at the forthcoming Centre Directors’ meeting that they were responsible for ensuring that funders within their area felt appreciated, and that the funders fully understood they were making a global contribution. Appreciation was expressed to Dan Fox of the Milbank Memorial Fund and to Ron Stamp for their contributions to this initiative over the years.
Action: Nick, Sally


5.         Chief Executive Officer – contract renewal

Nick Royle was absent from the following discussion:
Jim reported that he, Mark and Jordi had recently conducted the Chief Executive Officer’s annual appraisal and recommended that his contract be renewed for two years; this was approved. He would continue to have an appraisal annually, and would receive an annual cost of living salary increase in accordance with the appropriate NHS scale. The next appraisal should take place before Mark stepped down as Co-Chair, to provide continuity. Peter said the Co-ordinating Editors had recommended that the views of all entity leaders and key stakeholders who interact on a regular basis with the CEO should be solicited in future appraisals.  
Action: Mark, Steff